Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Miklós Poór:

Search results

Items: 1 to 20 of 32

1.

Interaction of Mycotoxin Alternariol with Serum Albumin.

Fliszár-Nyúl E, Lemli B, Kunsági-Máté S, Dellafiora L, Dall'Asta C, Cruciani G, Pethő G, Poór M.

Int J Mol Sci. 2019 May 12;20(9). pii: E2352. doi: 10.3390/ijms20092352.

2.

Interaction of Dihydrocitrinone with Native and Chemically Modified Cyclodextrins.

Faisal Z, Kunsági-Máté S, Lemli B, Szente L, Bergmann D, Humpf HU, Poór M.

Molecules. 2019 Apr 4;24(7). pii: E1328. doi: 10.3390/molecules24071328.

3.

Interaction of Chrysin and Its Main Conjugated Metabolites Chrysin-7-Sulfate and Chrysin-7-Glucuronide with Serum Albumin.

Mohos V, Fliszár-Nyúl E, Schilli G, Hetényi C, Lemli B, Kunsági-Máté S, Bognár B, Poór M.

Int J Mol Sci. 2018 Dec 17;19(12). pii: E4073. doi: 10.3390/ijms19124073.

4.

Interaction of the mycotoxin metabolite dihydrocitrinone with serum albumin.

Faisal Z, Vörös V, Lemli B, Derdák D, Kunsági-Máté S, Bálint M, Hetényi C, Csepregi R, Kőszegi T, Bergmann D, Sueck F, Humpf HU, Hübner F, Poór M.

Mycotoxin Res. 2019 May;35(2):129-139. doi: 10.1007/s12550-018-0336-z. Epub 2018 Nov 13.

PMID:
30426325
5.

A One-Step Extraction and Luminescence Assay for Quantifying Glucose and ATP Levels in Cultured HepG2 Cells.

Csepregi R, Temesfői V, Sali N, Poór M, W Needs P, A Kroon P, Kőszegi T.

Int J Mol Sci. 2018 Sep 8;19(9). pii: E2670. doi: 10.3390/ijms19092670.

6.

Interaction of 2'R-ochratoxin A with Serum Albumins: Binding Site, Effects of Site Markers, Thermodynamics, Species Differences of Albumin-binding, and Influence of Albumin on Its Toxicity in MDCK Cells.

Faisal Z, Derdák D, Lemli B, Kunsági-Máté S, Bálint M, Hetényi C, Csepregi R, Kőszegi T, Sueck F, Cramer B, Humpf HU, Poór M.

Toxins (Basel). 2018 Sep 1;10(9). pii: E353. doi: 10.3390/toxins10090353.

7.

Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes.

Mohos V, Bencsik T, Boda G, Fliszár-Nyúl E, Lemli B, Kunsági-Máté S, Poór M.

Biomed Pharmacother. 2018 Nov;107:777-784. doi: 10.1016/j.biopha.2018.08.068. Epub 2018 Aug 22.

PMID:
30142539
8.

Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics.

Faisal Z, Lemli B, Szerencsés D, Kunsági-Máté S, Bálint M, Hetényi C, Kuzma M, Mayer M, Poór M.

Mycotoxin Res. 2018 Nov;34(4):269-278. doi: 10.1007/s12550-018-0321-6. Epub 2018 Jul 16.

PMID:
30014206
9.

Green Fluorescent Protein-Based Viability Assay in a Multiparametric Configuration.

Csepregi R, Temesfői V, Poór M, Faust Z, Kőszegi T.

Molecules. 2018 Jun 28;23(7). pii: E1575. doi: 10.3390/molecules23071575.

10.

Interaction of Ochratoxin A and Its Thermal Degradation Product 2'R-Ochratoxin A with Human Serum Albumin.

Sueck F, Poór M, Faisal Z, Gertzen CGW, Cramer B, Lemli B, Kunsági-Máté S, Gohlke H, Humpf HU.

Toxins (Basel). 2018 Jun 22;10(7). pii: E256. doi: 10.3390/toxins10070256.

11.

Removal of Zearalenone and Zearalenols from Aqueous Solutions Using Insoluble Beta-Cyclodextrin Bead Polymer.

Poór M, Faisal Z, Zand A, Bencsik T, Lemli B, Kunsági-Máté S, Szente L.

Toxins (Basel). 2018 May 25;10(6). pii: E216. doi: 10.3390/toxins10060216.

12.

Pharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albumin.

Poór M, Boda G, Mohos V, Kuzma M, Bálint M, Hetényi C, Bencsik T.

Biomed Pharmacother. 2018 Jun;102:912-921. doi: 10.1016/j.biopha.2018.03.146. Epub 2018 Apr 5.

PMID:
29710546
13.

Complex Formation of Resorufin and Resazurin with Β-Cyclodextrins: Can Cyclodextrins Interfere with a Resazurin Cell Viability Assay?

Csepregi R, Lemli B, Kunsági-Máté S, Szente L, Kőszegi T, Németi B, Poór M.

Molecules. 2018 Feb 10;23(2). pii: E382. doi: 10.3390/molecules23020382.

14.

Interaction of α- and β-zearalenols with β-cyclodextrins.

Poór M, Zand A, Szente L, Lemli B, Kunsági-Máté S.

Molecules. 2017 Nov 6;22(11). pii: E1910. doi: 10.3390/molecules22111910.

15.

Investigation of Non-Covalent Interactions of Aflatoxins (B1, B2, G1, G2, and M1) with Serum Albumin.

Poór M, Bálint M, Hetényi C, Gődér B, Kunsági-Máté S, Kőszegi T, Lemli B.

Toxins (Basel). 2017 Oct 25;9(11). pii: E339. doi: 10.3390/toxins9110339.

16.

A novel luminol-based enhanced chemiluminescence antioxidant capacity microplate assay for use in different biological matrices.

Kőszegi T, Sali N, Raknić M, Horváth-Szalai Z, Csepregi R, Končić MZ, Papp N, Poór M.

J Pharmacol Toxicol Methods. 2017 Nov - Dec;88(Pt 2):153-159. doi: 10.1016/j.vascn.2017.09.256. Epub 2017 Sep 28.

PMID:
28962917
17.

Interaction of mycotoxin zearalenone with human serum albumin.

Poór M, Kunsági-Máté S, Bálint M, Hetényi C, Gerner Z, Lemli B.

J Photochem Photobiol B. 2017 May;170:16-24. doi: 10.1016/j.jphotobiol.2017.03.016. Epub 2017 Mar 27.

PMID:
28365492
18.

Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme.

Poór M, Boda G, Needs PW, Kroon PA, Lemli B, Bencsik T.

Biomed Pharmacother. 2017 Apr;88:574-581. doi: 10.1016/j.biopha.2017.01.092. Epub 2017 Jan 27.

PMID:
28135601
19.

Effects of phosphate binders on the gastrointestinal absorption of arsenate and of an SGLT2 inhibitor drug on the urinary excretion of arsenite in mice.

Poór M, Németi B, Gregus Z.

Environ Toxicol Pharmacol. 2017 Jan;49:179-187. doi: 10.1016/j.etap.2017.01.002. Epub 2017 Jan 3.

PMID:
28068585
20.

Structure related effects of flavonoid aglycones on cell cycle progression of HepG2 cells: Metabolic activation of fisetin and quercetin by catechol-O-methyltransferase (COMT).

Poór M, Zrínyi Z, Kőszegi T.

Biomed Pharmacother. 2016 Oct;83:998-1005. doi: 10.1016/j.biopha.2016.08.009. Epub 2016 Aug 12.

PMID:
27522262

Supplemental Content

Loading ...
Support Center